ArticleMedicina (Kaunas, Lithuania)2026

Erythrocyte Transfusion as an Independent Predictor of Survival but Not Immune-Related Toxicity in Nivolumab-Treated Metastatic NSCLC: A Multicenter Cohort.

Mehmet Cem Fidan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.